Clover Technologies Group Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Clover Technologies Group's estimated annual revenue is currently $417.8M per year.(i)
  • Clover Technologies Group's estimated revenue per employee is $294,000

Employee Data

  • Clover Technologies Group has 1421 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.9M3352%N/AN/A
#2
$181.1M5993%N/AN/A
#3
$0.7M60%N/AN/A
#4
$14M632%N/AN/A
#5
$12.1M6425%N/AN/A
#6
$11.5M6127%N/AN/A
#7
$1.5M1417%N/AN/A
#8
$12.3M6828%N/AN/A
#9
$7.4M442%N/AN/A
#10
$7.6M31-18%N/AN/A
Add Company

Since 1997, Clover has been a leader in the design, manufacture and distribution of compatible consumable printing supplies, including laser toner and inkjet cartridges - large categories of the rapidly growing digital imaging supplies industry. Clover's product line also includes compatible laser fax cartridges, copier toner cartridges, thermal transfer fax supplies and other consumable imaging supplies. Clover distributes its products under the Image Excellence® brand name, as well as its customers' private label brands. In addition to manufacturing compatible products, Clover is a leading distributor of OEM-branded imaging supplies to leading dealers and resellers nationwide.

keywords:N/A

N/A

Total Funding

1421

Number of Employees

$417.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clover Technologies Group's People

NameTitleEmail/Phone
1
VP Mono R&DReveal Email/Phone
2
CEOReveal Email/Phone

Clover Technologies Group News

2022-04-20 - Nutritional Lipid Market Overview, Demand, Top Players ...

This team is determined on understanding client's business and their needs ... Nutritional Lipid Market Analysis and Forecast, By Technology.

2022-04-19 - Base edit your way to better crops

Gao's is one of a growing number of research groups turning to ... Biomedical researchers have pounced on these technologies as tools for...

2022-04-13 - AstraZeneca Touts Evusheld's Efficacy in High-Risk Patients

Three-quarters of the participant group selected were considered high ... The SCB-2019 vaccine relies upon Clover's Trimer-Tag technology to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$358.3M17396%$65M
#2
$1320.5M20721%N/A
#3
$998.4M2459N/AN/A
#4
$4670.2M9450N/AN/A
#5
$1700M10229N/AN/A